NCT01935180

Brief Summary

Effectiveness of screening colonoscopy in cancer prevention relies on the detection and removal of adenomatous polyps. However, a substantial rate of adenomas is missed during a colonoscopy. It has been estimated that two thirds of missed adenomas are located on the proximal aspect of colonic folds. Attaching a transparent cap to the tip of a colonoscope may allow examination of the proximal aspect of colonic folds, and some early studies have suggested an increased polyp and adenoma detection using this technology. However, the studies have in part substantial methodological limitations (e.g. missing polyp histology, single endoscopist study, polyps not removed at the time of detection). Therefore, at this point it is unclear whether cap assisted colonoscopy may improve adenoma detection. The objective of this study is to evaluate whether cap assisted colonoscopy improves adenoma detection. The investigators propose a two-center multiple endoscopists randomized controlled trial. Patients will be randomized to cap assisted colonoscopy or standard high definition white light colonoscopy. The cap is a 4mm commercially available transparent cap that is attached to the tip of the colonoscopy. Primary outcome measure is the adenoma detection rate (mean number of adenoma per patient). The investigators will assess and adjust for possible variables that can affect adenoma detection, including withdrawal time and quality of colon preparation. As a secondary outcome of interest the investigators will evaluate a possible learning curve effect among all endoscopists (a minimum of six) new to this method. In addition the investigators will evaluate whether cap assisted endoscopy improves real time prediction of polyp histology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,148

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2010

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 19, 2012

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
1.3 years until next milestone

First Posted

Study publicly available on registry

September 4, 2013

Completed
3.7 years until next milestone

Results Posted

Study results publicly available

May 30, 2017

Completed
Last Updated

September 25, 2018

Status Verified

August 1, 2018

Enrollment Period

1.4 years

First QC Date

January 19, 2012

Results QC Date

March 4, 2017

Last Update Submit

August 27, 2018

Conditions

Keywords

colon polypsadenoma resectioncolon cancer screeningcolonoscopypolyp detection

Outcome Measures

Primary Outcomes (1)

  • Mean Number of Adenomas

    Mean number of adenomas per patient in each group.

    duration of colonoscopy

Secondary Outcomes (6)

  • Adenoma Detection Rate

    duration of colonoscopy

  • Advanced Adenoma Detection Rate

    duration of colonoscopy

  • Quality of Bowel Preparation

    duration of colonoscopy

  • Withdrawal Time

    time of colonoscope withdrawal

  • Ease of Terminal Ileum Intubation

    during colonoscopy

  • +1 more secondary outcomes

Study Arms (2)

Standard colonoscopy

NO INTERVENTION

Cap assisted colonoscopy

ACTIVE COMPARATOR

A transparent cap will be affixed to tip of the high-definition wide angle colonoscope.

Device: Colonoscopy Cap

Interventions

4mm transparent cap (Olympus) mounted to the tip of a colonoscope.

Cap assisted colonoscopy

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Patients with known inflammatory bowel disease or active colitis
  • Patients with familial adenomatous polyposis or other genetic syndromes that are associated with a high number of colonic polyps
  • Patients who are receiving an emergency colonoscopy
  • Poor general health (ASA class \> 3)
  • Patients on coumadin at the time of the procedure or with a coagulopathy and an elevated INR ≥ 1.5, or platelets \< 50
  • Patients who do not consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03756, United States

Location

White River Junction VAMC

White River Junction, Vermont, 05009, United States

Location

Related Publications (3)

  • von Renteln D, Kaltenbach T, Rastogi A, Anderson JC, Rosch T, Soetikno R, Pohl H. Simplifying Resect and Discard Strategies for Real-Time Assessment of Diminutive Colorectal Polyps. Clin Gastroenterol Hepatol. 2018 May;16(5):706-714. doi: 10.1016/j.cgh.2017.11.036. Epub 2017 Nov 23.

  • von Renteln D, Robertson DJ, Bensen S, Pohl H. Prolonged cecal insertion time is associated with decreased adenoma detection. Gastrointest Endosc. 2017 Mar;85(3):574-580. doi: 10.1016/j.gie.2016.08.021. Epub 2016 Aug 31.

  • Pohl H, Bensen SP, Toor A, Gordon SR, Levy LC, Berk B, Anderson PB, Anderson JC, Rothstein RI, MacKenzie TA, Robertson DJ. Cap-assisted colonoscopy and detection of Adenomatous Polyps (CAP) study: a randomized trial. Endoscopy. 2015 Oct;47(10):891-7. doi: 10.1055/s-0034-1392261. Epub 2015 Jun 30.

MeSH Terms

Conditions

Adenomatous PolypsColonic Polyps

Condition Hierarchy (Ancestors)

AdenomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsIntestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Heiko Pohl
Organization
VA Medical Center

Study Officials

  • Heiko Pohl

    White River Junction VAMC, Dartmouth Medical School

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

January 19, 2012

First Posted

September 4, 2013

Study Start

December 1, 2010

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

September 25, 2018

Results First Posted

May 30, 2017

Record last verified: 2018-08

Locations